FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386629002> ?p ?o ?g. }

• W4386629002 endingPage "5921" @default.
• W4386629002 startingPage "5921" @default.
• W4386629002 abstract "In spite of the widespread use of lifestyle modifications programs, many patients with PCOS are obese and prevalence of obesity in PCOS remains high. In this study, we present the data on the use of semaglutide, an incretin mimetic drug, in obese PCOS patients who were unresponsive to a lifestyle modification program. Twenty-seven obese patients with a diagnosis of PCOS, who did not reduce their body weight by a lifestyle modification program, were included in this study and treated by semaglutide, 0.5 mg subcutaneously once a week. After three months of treatment, an improvement in body weight with a mean decrease in body weight of 7.6 kg and a mean BMI loss of 3.1 was observed, while very few side effects were reported. Almost 80% of the studied obese PCOS patients obtained at least a 5% decrease in their body weight. Only a few patients (22%) obtained a decrease in body weight lower than 5% and were considered non-responsive to semaglutide, at least at the used doses. These patients presented a more severe obesity than responsive patients. Independently of results on body weight, and in patients who did not obtain a 5% decrease in their body weight, insulin basal values decreased, and HOMA-IR improved. Fasting blood glucose normalized in 80% of semaglutide-treated IFG PCOS women. In patients who were responsive to semaglutide (weight loss > 5%), the treatment was continued for additional three months. Weight loss slowed but continued and, at the end of the six months of therapy, the mean body weight loss was 11.5 kg and mean BMI reduced from 34.4 to 29.4. A total of 80% of responsive patients normalized menstrual cycles. In conclusion, treatment with semaglutide, at low doses, significantly reduces body weight in almost 80% of obese PCOS patients who were unresponsive to a previous lifestyle plan. It is often associated with the normalization of menstrual cycles, and these important results are obtained with very few side effects." @default.
• W4386629002 created "2023-09-13" @default.
• W4386629002 creator A5036716710 @default.
• W4386629002 creator A5058480938 @default.
• W4386629002 date "2023-09-12" @default.
• W4386629002 modified "2023-10-17" @default.
• W4386629002 title "Semaglutide Treatment of Excessive Body Weight in Obese PCOS Patients Unresponsive to Lifestyle Programs" @default.
• W4386629002 cites W1483604492 @default.
• W4386629002 cites W1577097214 @default.
• W4386629002 cites W1836408129 @default.
• W4386629002 cites W2005334239 @default.
• W4386629002 cites W2030643176 @default.
• W4386629002 cites W2040874437 @default.
• W4386629002 cites W2053105417 @default.
• W4386629002 cites W2109366467 @default.
• W4386629002 cites W2135480007 @default.
• W4386629002 cites W2150346446 @default.
• W4386629002 cites W2168771527 @default.
• W4386629002 cites W2346183877 @default.
• W4386629002 cites W2555053373 @default.
• W4386629002 cites W2623213129 @default.
• W4386629002 cites W2884536266 @default.
• W4386629002 cites W2917479147 @default.
• W4386629002 cites W3129305070 @default.
• W4386629002 cites W3138431202 @default.
• W4386629002 cites W3196907090 @default.
• W4386629002 cites W3210916260 @default.
• W4386629002 cites W4200034727 @default.
• W4386629002 cites W4207005829 @default.
• W4386629002 cites W4210832490 @default.
• W4386629002 cites W4244088697 @default.
• W4386629002 cites W4251646064 @default.
• W4386629002 cites W4292263170 @default.
• W4386629002 cites W4297146941 @default.
• W4386629002 cites W4306403312 @default.
• W4386629002 cites W4385431560 @default.
• W4386629002 doi "https://doi.org/10.3390/jcm12185921" @default.
• W4386629002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37762862" @default.
• W4386629002 hasPublicationYear "2023" @default.
• W4386629002 type Work @default.
• W4386629002 citedByCount "0" @default.
• W4386629002 crossrefType "journal-article" @default.
• W4386629002 hasAuthorship W4386629002A5036716710 @default.
• W4386629002 hasAuthorship W4386629002A5058480938 @default.
• W4386629002 hasBestOaLocation W43866290021 @default.
• W4386629002 hasConcept C126322002 @default.
• W4386629002 hasConcept C134018914 @default.
• W4386629002 hasConcept C147583825 @default.
• W4386629002 hasConcept C2777180221 @default.
• W4386629002 hasConcept C2781308992 @default.
• W4386629002 hasConcept C2909862629 @default.
• W4386629002 hasConcept C511355011 @default.
• W4386629002 hasConcept C544821477 @default.
• W4386629002 hasConcept C555293320 @default.
• W4386629002 hasConcept C71924100 @default.
• W4386629002 hasConceptScore W4386629002C126322002 @default.
• W4386629002 hasConceptScore W4386629002C134018914 @default.
• W4386629002 hasConceptScore W4386629002C147583825 @default.
• W4386629002 hasConceptScore W4386629002C2777180221 @default.
• W4386629002 hasConceptScore W4386629002C2781308992 @default.
• W4386629002 hasConceptScore W4386629002C2909862629 @default.
• W4386629002 hasConceptScore W4386629002C511355011 @default.
• W4386629002 hasConceptScore W4386629002C544821477 @default.
• W4386629002 hasConceptScore W4386629002C555293320 @default.
• W4386629002 hasConceptScore W4386629002C71924100 @default.
• W4386629002 hasIssue "18" @default.
• W4386629002 hasLocation W43866290021 @default.
• W4386629002 hasLocation W43866290022 @default.
• W4386629002 hasOpenAccess W4386629002 @default.
• W4386629002 hasPrimaryLocation W43866290021 @default.
• W4386629002 hasRelatedWork W1966504330 @default.
• W4386629002 hasRelatedWork W1979139803 @default.
• W4386629002 hasRelatedWork W2013644072 @default.
• W4386629002 hasRelatedWork W2014830377 @default.
• W4386629002 hasRelatedWork W2019443801 @default.
• W4386629002 hasRelatedWork W2037631372 @default.
• W4386629002 hasRelatedWork W2152437371 @default.
• W4386629002 hasRelatedWork W2748952813 @default.
• W4386629002 hasRelatedWork W3212875906 @default.
• W4386629002 hasRelatedWork W4213302520 @default.
• W4386629002 hasVolume "12" @default.
• W4386629002 isParatext "false" @default.
• W4386629002 isRetracted "false" @default.
• W4386629002 workType "article" @default.